Organovo Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;'>OH</div>
ONVO -- USA Stock  

USD 13.59  0.34  2.57%

The stock is still going through an active upward rally. As some millenniums are still trying to avoid healthcare space, I will try to outline Organovo Holdings a little further in order to understand its potential as a viable investment. We will evaluate why recent Organovo Holdings price moves suggest a bounce in January.
Published over a month ago
View all stories for Organovo Holdings | View All Stories
Do analysts believe Organovo Holdings (NASDAQ:ONVO) will continue to rise?
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Organovo Holdings has an asset utilization ratio of 0.44 percent. This suggests that the company is making $0.00441 for each dollar of assets. An increasing asset utilization means that Organovo Holdings is more efficient with each dollar of assets it utilizes for everyday operations.
What is the right price you would pay to acquire a share of Organovo Holdings? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated. Please read more on our stock advisor page.

How important is Organovo Holdings's Liquidity

Organovo Holdings financial leverage refers to using borrowed capital as a funding source to finance Organovo Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Organovo Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Organovo Holdings's total debt and its cash.

How Organovo utilizes its cash?

To perform a cash flow analysis of Organovo Holdings, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Organovo Holdings is receiving and how much cash it distributes out in a given period. The Organovo Holdings cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Organovo Holdings Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (10.46 Million)

Acquisition by Keith Murphy of 65000 shares of Organovo Holdings subject to Rule 16b-3

Legal trades by Organovo Holdings insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Organovo insider trading alert for grant of stock option (right to buy) by Keith Murphy, Executive Chairman, on 11th of December 2020. This event was filed by Organovo Holdings Inc with SEC on 2020-12-11. Statement of changes in beneficial ownership - SEC Form 4. Keith Murphy currently serves as chairman, ceo and president member of audit committee and member of science and technology committee of Organovo Holdings [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Is Organovo a risky opportunity?

Let's check the volatility. Organovo is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Organovo (NASDAQ:ONVO) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. picking up a share of an Organovo Holdings stock makes you a part-owner of that company.

Our take on today Organovo Holdings rise

The semi deviation is down to 3.81 as of today. Organovo Holdings is displaying above-average volatility over the selected time horizon. Investors should scrutinize Organovo Holdings independently to ensure intended market timing strategies are aligned with expectations about Organovo Holdings volatility.

The Current Takeaway on Organovo Holdings Investment

Whereas many of the other players under the diagnostics & research industry are still a bit expensive, Organovo Holdings may offer a potential longer-term growth to institutional investors. To conclude, as of the 19th of December 2020, we believe that Organovo Holdings is currently overvalued with high chance of distress in the next two years. Our latest 30 days recommendation on the company is Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Organovo Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com